Kratom Industry Group Has First Qualifier For Its GMP Standards Exceeding FDA's
Executive Summary
Online retailer and supplement brand Kraken Kratom is first business American Kratom Association recognized with its GMP Qualified Vendor status. But, FDA reiterates kratom should not be used in supplements until an NDI notification is submitted showing a reasonable expectation of safety for its intended use, and DEA still has pending a proposed order to schedule kratom constituent ingredients as controlled substances.
You may also be interested in...
Another Notice For Comments On Kratom: Cue Second Wave Of Support For Botanical In US?
FDA states in Federal Register notice that WHO has requested information on whether kratom – mitragynine, 7-hydroxymitragynine – should be added to the United Nations’ schedule of controlled substances.
With Seizure in Florida, FDA Targets Kratom As Unsafe For Any Use
Kratom industry says complaint filed in Florida federal court shows FDA’s switching reasons to stop all sales of the ingredient in the US.
US HHS Pulled Recommendation To Make Kratom A Controlled Substance, But Kept Mum On Change
HHS released to industry proponents Reps. Mark Pocan and Morgan Griffith the letter it submitted in 2018 notifying DEA that it was rescinding recommendation it made in 2017 to list kratom active ingredients mitragynine and 7-hydroxymitragynine under Schedule I of the CSA.